Boehringer Ingelheim Articles

$650 Million Settlement: Pradaxa Maker Wants To Avoid Litigation

A $650 million settlement is a hefty chunk of change, but it was a better outcome than the alternative for one drug maker. Boehringer Ingelheim, a German pharmaceutical company, was facing multiple lawsuits after families claimed Pradaxa, a blood thinner, …